Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (131-140 of 213) with videos related to

Pageof 22
Sort By:
European Journal of Neurology|March 11, 2024
Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profilesGeorgios Mangioris, Thorvardur R Halfdanarson, Vanda A Lennon, et al.
Pancreas|October 21, 2016
Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine TumorsNancy Sharma, Boris G Naraev, Eric G Engelman, et al.
JCO Precision Oncology|September 4, 2024
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown PrimaryHarry E Fuentes Bayne, Pashtoon M Kasi, Li Ma, et al.
World Journal of Gastrointestinal Oncology|May 31, 2012
Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patientsTaher Abu Hejleh, Barry R Deyoung, Eric Engelman, et al.
Case Reports in Gastroenterology|December 7, 2016
Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature ReviewJames M Chang, Nitin N Katariya, Dora M Lam-Himlin, et al.
In Vivo (Athens, Greece)|August 31, 2023
Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular CarcinomaJennifer L Leiting, Matthew C Hernandez, John R Bergquist, et al.
Annals of Surgical Oncology|April 30, 2024
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and PeritoneumHallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, et al.
JAMA Network Open|August 9, 2020
Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysisFang Yang, Svetomir N Markovic, Julian R Molina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and ParagangliomaGokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumorsMuhammad Wasif Saif, Rohan Parikh, David Ray, et al.
Pageof 22

Showing results (131-140 of 213) with videos related to

Sort By:
Pageof 22
European Journal of Neurology|March 11, 2024
Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profilesGeorgios Mangioris, Thorvardur R Halfdanarson, Vanda A Lennon, et al.
Pancreas|October 21, 2016
Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine TumorsNancy Sharma, Boris G Naraev, Eric G Engelman, et al.
JCO Precision Oncology|September 4, 2024
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown PrimaryHarry E Fuentes Bayne, Pashtoon M Kasi, Li Ma, et al.
World Journal of Gastrointestinal Oncology|May 31, 2012
Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patientsTaher Abu Hejleh, Barry R Deyoung, Eric Engelman, et al.
Case Reports in Gastroenterology|December 7, 2016
Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature ReviewJames M Chang, Nitin N Katariya, Dora M Lam-Himlin, et al.
In Vivo (Athens, Greece)|August 31, 2023
Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular CarcinomaJennifer L Leiting, Matthew C Hernandez, John R Bergquist, et al.
Annals of Surgical Oncology|April 30, 2024
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and PeritoneumHallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, et al.
JAMA Network Open|August 9, 2020
Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysisFang Yang, Svetomir N Markovic, Julian R Molina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and ParagangliomaGokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
Journal of Gastrointestinal Oncology|August 9, 2019
Medical record review of transition to lanreotide following octreotide for neuroendocrine tumorsMuhammad Wasif Saif, Rohan Parikh, David Ray, et al.
Pageof 22